Literature DB >> 1695779

Clinical manifestations of benign prostatic hyperplasia and indications for therapeutic intervention.

M M Christensen1, R C Bruskewitz.   

Abstract

The symptomatology of benign prostatic hyperplasia is a complex issue, and the clear-cut indications for therapeutic intervention are few. Overflow incontinence is a clear indication for treatment, and it seems prudent to recommend surgical intervention for patients with large postvoiding residual volumes. Acute urinary retention, recurrent infection, azotemia, and severe hematuria are other strong indications. When the indications are less clear, the patient's perspective on the impact of prostate disease on his life is important.

Entities:  

Mesh:

Year:  1990        PMID: 1695779

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  18 in total

Review 1.  Transurethral microwave thermotherapy in benign prostatic hyperplasia.

Authors:  P Minnee; F M Debruyne; J J de la Rosette
Journal:  Curr Urol Rep       Date:  2000-08       Impact factor: 3.092

2.  The medical therapy of prostatic symptoms study: what will we learn?

Authors:  Kevin M Slawin
Journal:  Rev Urol       Date:  2003

3.  The medical therapy of prostatic symptoms study: what will we learn?

Authors:  Kevin M Slawin
Journal:  Rev Urol       Date:  2003

Review 4.  Assessment of alpha1-adrenoceptor antagonists in benign prostatic hyperplasia based on the receptor occupancy theory.

Authors:  Kaori Ito; Hisakazu Ohtani; Yasufumi Sawada
Journal:  Br J Clin Pharmacol       Date:  2006-10-17       Impact factor: 4.335

Review 5.  Benign prostatic hyperplasia.

Authors:  R J Simpson
Journal:  Br J Gen Pract       Date:  1997-04       Impact factor: 5.386

6.  Annual costs of benign prostatic hyperplasia in New Zealand.

Authors:  W G Scott; H M Scott
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

Review 7.  Serenoa repens for benign prostatic hyperplasia.

Authors:  James Tacklind; Roderick Macdonald; Indy Rutks; Judith U Stanke; Timothy J Wilt
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 8.  Neuronal nitric oxide synthase in the neural pathways of the urinary bladder.

Authors:  Y Zhou; E A Ling
Journal:  J Anat       Date:  1999-05       Impact factor: 2.610

Review 9.  Pygeum africanum for benign prostatic hyperplasia.

Authors:  T Wilt; A Ishani; R Mac Donald; I Rutks; G Stark
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 10.  Serenoa repens for benign prostatic hyperplasia.

Authors:  James Tacklind; Roderick MacDonald; Indy Rutks; Timothy J Wilt
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.